UNICANCER Clinical Trials
Sponsors / UNICANCER
UNICANCER is listed as the lead sponsor on 125 clinical trials registered with ClinicalTrials.gov. 12 trials are actively recruiting participants, 14 remain active without open enrollment, and 75 have concluded. 13 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. The cumulative planned enrollment figure across all listed trials is 126,650 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
125
Total Trials
12
Recruiting
14
Other Active
75
Completed
13
Terminated / Withdrawn
126,650
Total Enrollment
Termination reasons: Other46% · Recruitment31% · Safety23%
Recent Terminations
- Metastatic Colorectal Cancer"Following the presentation of the SUNLIGHT study results at ASCO GI and the rapid change in patient management in the majority of centers, the IDMC experts recommended halting inclusion in the SOREGATT study with immediate effect."
- Breast Cancer, PI3K, Alpelisib"Study was halted Prematurely for low recruitment."
- Carcinoma, Squamous Cell of Head and Neck"futilty of the treatment"
- Anal Cancer"Inadequate toxicity"
- Colorectal Cancer"Toxicity and lack of efficacy"
- Breast Cancer"Toxicity issues"
- Adenocarcinoma"low recruitment"
- Colorectal Cancer"insuffisient recruitment"
- NCT00674414 Phase PHASE2Breast Cancer"IDMC decision due to accrual issue (82 pts accrued / 120 expected)"
- NCT00053911 Phase PHASE3Breast Cancer
Active Trials (14 total)
- NCT06475352
- NCT07230613
- Localized Cancer PHASE2NCT07262489
- Osteosarcoma PHASE2NCT03643133
- NCT03143322
- Advanced Breast Cancer PHASE2NCT07259226
- NCT05973864
- NCT07187726
- NCT03672331
- Cancer Metastatic PHASE3NCT04158362
- CIC-Rearranged Sarcoma PHASE2NCT02389244
- NCT05582122
- Breast Cancers PHASE3NCT06606730
- Breast Cancer PHASE3NCT01564056
- NCT04115007
- Basal Cell Carcinoma PHASE3NCT05078047
- NCT01247233
- NCT01376752
- NCT05443087
- Advanced Soft-tissue Sarcoma PHASE3NCT04757337